skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: First comprehensive structural and biophysical analysis of MAPK13 inhibitors targeting DFG-in and DFG-out binding modes

Journal Article · · Biochimica et Biophysica Acta - General Subjects
 [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1]
  1. Washington Univ. School of Medicine, St. Louis, MO (United States)
+ Show Author Affiliations

Background: P38 MAP kinases are centrally involved in mediating extracellular signaling in various diseases. While much attention has previously been focused on the ubiquitously expressed family member MAPK14 (p38α), recent studies indicate that family members such as MAPK13 (p38δ) display a more selective cellular and tissue expression and might therefore represent a specific kinase to target in certain diseases. Methods: To facilitate the design of potent and specific inhibitors, we present in this paper the structural, biophysical, and functional characterization of two new MAPK13-inhibitor complexes, as well as the first comprehensive structural, biophysical, and functional analysis of MAPK13 complexes with four different inhibitor compounds of greatly varying potency. Results: These inhibitors display IC50 values either in the nanomolar range or micromolar range (> 800-fold range). The nanomolar inhibitors exhibit much longer ligand-enzyme complex half-lives compared to the micromolar inhibitors as measured by biolayer interferometry. Crystal structures of the MAPK13 inhibitor complexes reveal that the nanomolar inhibitors engage MAPK13 in the DFG-out binding mode, while the micromolar inhibitors are in the DFG-in mode. Detailed structural and computational docking analyses suggest that this difference in binding mode engagement is driven by conformational restraints imposed by the chemical structure of the inhibitors, and may be fortified by an additional hydrogen bond to MAPK13 in the nanomolar inhibitors. Conclusions: These studies provide a structural basis for understanding the differences in potency exhibited by these inhibitors. General significance: They also provide the groundwork for future studies to improve specificity, potency, pharmacodynamics, and pharmacokinetic properties.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS); Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States). Advanced Light Source (ALS)
Sponsoring Organization:
USDOE Office of Science (SC), Biological and Environmental Research (BER); USDOE Office of Science (SC), Basic Energy Sciences (BES); National Institutes of Health (NIH); American Heart Association (AHA)
Grant/Contract Number:
T32-GM007067; AC02-06CH11357; AC02-05CH11231
OSTI ID:
1329425
Alternate ID(s):
OSTI ID: 1396466
Journal Information:
Biochimica et Biophysica Acta - General Subjects, Vol. 1860, Issue 11; ISSN 0304-4165
Publisher:
ElsevierCopyright Statement
Country of Publication:
United States
Language:
ENGLISH
Citation Metrics:
Cited by: 11 works
Citation information provided by
Web of Science

References (42)

The role of p38 mitogen-activated protein kinase in the pathogenesis of inflammatory bowel disease: Role of p38 MAPK in IBD journal September 2011
The p38α Kinase Plays a Central Role In Inflammation journal August 2009
Targeting kinases for the treatment of inflammatory diseases journal July 2010
Computational Insights for the Discovery of Non-ATP Competitive Inhibitors of MAP Kinases journal March 2012
Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor journal December 2011
X-ray structure of p38α bound to TAK-715: comparison with three classic inhibitors journal July 2012
Design and Synthesis of Inhaled p38 Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease journal November 2011
Essential Role of p38α MAP Kinase in Placental but Not Embryonic Cardiovascular Development journal July 2000
Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis journal September 2000
Requirement for p38α in Erythropoietin Expression journal July 2000
Pathway to the Clinic: Inhibition of P38 MAP Kinase. A Review of Ten Chemotypes Selected for Development journal September 2005
p38  and p38  kinases regulate the Toll-like receptor 4 (TLR4)-induced cytokine production by controlling ERK1/2 protein kinase pathway activation journal June 2012
New Insights into the p38 γ and p38 δ MAPK Pathways journal November 2012
Regulation of PKD by the MAPK p38δ in Insulin Secretion and Glucose Homeostasis journal January 2009
Regulation of PTEN activity by p38δ-PKD1 signaling in neutrophils confers inflammatory responses in the lung journal November 2012
Pro-Oncogenic Role of Alternative p38 Mitogen-Activated Protein Kinases p38γ and p38δ, Linking Inflammation and Cancer in Colitis-Associated Colon Cancer journal September 2014
Combined deletion of p38γ and p38δ reduces skin inflammation and protects from carcinogenesis journal May 2015
Alternative p38 MAPKs Are Essential for Collagen-Induced Arthritis: p38γ and p38δ in Arthritis journal April 2014
IL-13–induced airway mucus production is attenuated by MAPK13 inhibition journal November 2012
MAP Kinase p38Inhibitors: Clinical Results and an Intimate Look at Their Interactions with p38α Protein journal December 2005
The crystal structure of phosphorylated MAPK13 reveals common structural features and differences in p38 MAPK family activation journal March 2015
[20] Processing of X-ray diffraction data collected in oscillation mode book January 1997
Coot model-building tools for molecular graphics journal November 2004
PHENIX : building new software for automated crystallographic structure determination journal October 2002
LigPlot+: Multiple Ligand–Protein Interaction Diagrams for Drug Discovery journal October 2011
Collaboration gets the most out of software journal September 2013
Data publication with the structural biology data grid supports live analysis journal March 2016
Glide:  A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening journal March 2004
Glide:  A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy journal March 2004
BIRB796 Inhibits All p38 MAPK Isoforms in Vitro and in Vivo journal May 2005
A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib): Relationships among Protein Conformation, Inhibitor Off-Rate, and Receptor Activity in Tumor Cells journal September 2004
Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes journal August 2008
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase journal September 2000
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site journal March 2002
Structural basis of inhibitor selectivity in MAP kinases journal September 1998
The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability journal September 2007
Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination journal October 2006
Inhibition of pro-inflammatory cytokine production by the dual p38/JNK2 inhibitor BIRB796 correlates with the inhibition of p38 signaling journal February 2009
Accurate Prediction of the Relative Potencies of Members of a Series of Kinase Inhibitors Using Molecular Docking and MM-GBSA Scoring journal August 2006
ESPript/ENDscript: extracting and rendering sequence and 3D information from atomic structures of proteins journal July 2003
X-Ray Diffraction data from MAPK13 complex with compound 58, source of 5EKN structure dataset January 2016
X-Ray Diffraction data from MAPK13 complex with compound 117, source of 5EKO structure dataset January 2016

Cited By (2)

Synchrotron Big Data Science journal September 2018
Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase journal January 2019

Similar Records

Structural Characterization of Proline-rich Tyrosine Kinase 2 (PYK2) Reveals a Unique (DFG-out) Conformation and Enables Inhibitor Design
Journal Article · Thu May 21 00:00:00 EDT 2009 · J. Biol. Chem. · OSTI ID:1329425
+10 more
Structural Analysis of DFG-in and DFG-out Dual Src-Abl Inhibitors Sharing a Common Vinyl Purine Template
Journal Article · Thu Sep 30 00:00:00 EDT 2010 · Chem. Biol. Drug Des. · OSTI ID:1329425
+6 more
Discovery of Type II Inhibitors of TGFβ-Activated Kinase 1 (TAK1) and Mitogen-Activated Protein Kinase Kinase Kinase Kinase 2 (MAP4K2)
Journal Article · Wed Jul 30 00:00:00 EDT 2014 · Journal of Medicinal Chemistry · OSTI ID:1329425
+16 more

Related Subjects

59 BASIC BIOLOGICAL SCIENCES
p38 kinase
Structure-based drug design
Chronic inflammatory lung disease
Kinase inhibitor
Inhibitor half-lives
Differential scanning fluorimetry